Thrivent Financial For Lutherans Ironwood Pharmaceuticals Inc Transaction History
Thrivent Financial For Lutherans
- $51.6 Billion
- Q4 2024
A detailed history of Thrivent Financial For Lutherans transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 108,850 shares of IRWD stock, worth $167,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108,850
Previous 110,389
1.39%
Holding current value
$167,629
Previous $455,000
5.93%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IRWD
# of Institutions
244Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$35.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$30.1 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$25.2 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$18.1 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$14.6 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $236M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...